Sponsor

Secura Bio Limited

Ireland 32 Molesworth Street, D02 Y512 Dublin, Ireland

About the sponsor

Secura Bio Limited is active in blood cancer research, with a particular focus on nodal T-cell lymphoma and disease that has relapsed or become refractory after prior treatment.

T-cell lymphoma
Relapsed/refractory disease
Nodal lymphoma

The sponsor’s current clinical activity centers on a rare lymphoid malignancy affecting patients with limited treatment options.

About Specializations

Secura Bio Limited runs clinical trials in conditions such as Adult T-cell lymphoma/leukaemia refractory, among others.

Adult T-cell lymphoma/leukaemia refractory

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Adult T-cell lymphoma/leukaemia refractory

Recruiting

Registered drugNo placebo

Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:DUVELISIB
Sponsor:Secura Bio Limited

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →